Anondita Medicare is a leading manufacturer of male condoms with a variety of flavors, with their flagship product marketed under the brand COBRA. The company has an installed production capacity of nearly 562 million condoms per annum, certified by JP Sood, Chartered Engineer, on June 4, 2025.

The Anondita Medicare IPO 2025 is a Book Built Issue of ₹ 69.50 Crores, consisting entirely of a Fresh Issue of 47.93 Lakh shares. The IPO subscription period opens on 22nd August 2025 and closes on 26th August 2025, with allotment expected on 28th August 2025. The shares are proposed to be listed on NSE SME tentatively on 1st September 2025.

The IPO share price band is ₹ 137 to ₹ 145 per equity share. At the upper end, the company’s market capitalization will be ₹ 262.26 Crores. The lot size is 1,000 shares, with a minimum investment of 2 lots or ₹ 2,90,000.

NARNOLIA FINANCIAL SERVICES LIMITED is the book running lead manager, MAASHITLA SECURITIES PRIVATE LIMITED is the registrar, and Mansi Share Stock Broking Private Limited acts as the market maker.

The Grey Market Premium (GMP) for Anondita Medicare is currently ₹ 25, indicating potential listing gains of 17.24%. Investors should note that GMP depends on unorganized demand and supply and is for educational purposes only.

Anchor investors have subscribed for 13,52,000 shares at ₹ 145 per share, raising ₹ 19.60 Crores, allocated from the Qualified Institutional Buyers (QIBs) portion.

The IPO proceeds will be used for growth and expansion:

• ₹ 600.00 Lakh for capital expenditure, including purchase of equipment and machinery.

• ₹ 3,500.00 Lakh for working capital requirements.

• Remaining funds for unidentified acquisitions and general corporate purposes.

The company’s leadership comprises Mr. Anupam Ghosh, Managing Director and Promoter with 25 years of experience, Mrs. Sonia Ghosh, Whole Time Director and Promoter with 10 years of administrative and HR experience, and Mr. Reshant Ghosh, Whole Time Director and Promoter with 3 years of marketing expertise, managing distribution networks and market strategies.

Financial performance shows consistent growth:

• Revenue from operations: ₹ 7,712.95 Lakh (FY25), ₹ 4,655.53 Lakh (FY24), ₹ 3,613.97 Lakh (FY23)

• EBITDA: ₹ 2,579.11 Lakh (FY25), ₹ 921.53 Lakh (FY24), ₹ 380.30 Lakh (FY23)

• Profit after Tax (PAT): ₹ 1,641.66 Lakh (FY25), ₹ 384.47 Lakh (FY24), ₹ 34.69 Lakh (FY23)

Key IPO metrics include pre-issue EPS ₹ 14.04, post-issue EPS ₹ 8.73, pre-issue P/E ratio 10.32x, post-issue P/E ratio 16.60x (against industry P/E 110x), ROCE 37.42%, ROE 41.71%, and RoNW 41.71%, indicating a fairly priced IPO.

Investors can check allotment status online from 28th August 2025 via the registrar’s portal using application number, PAN, or DP Client ID. Monitoring subscription trends, GMP, and anchor investor allocation will help investors make informed decisions.

Given the Grey Market Premium of ₹ 25 and strong financial performance, risky investors may consider applying to the Anondita Medicare IPO for potential listing gains.

The Upcoming IPOs in this week and coming weeks are Anlon Healthcare, NIS Management, Sattva Engineering Construction, Globtier Infotech, Current Infraprojects, Anondita Medicare, Classic Electrodes (India), Vikran Engineering, Shivashrit Foods.

The Current active IPO are ARC Insulation & Insulators, Mangal Electrical Industries, LGT Business Connextions, Vikram Solar, Gem Aromatics, Shreeji Shipping Global, Patel Retail.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.

Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.